IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,541,000 | +133.9% | 41,650 | -2.5% | 0.15% | +120.0% |
| Q2 2020 | $1,514,000 | +244.1% | 42,715 | +30.9% | 0.07% | +536.4% |
| Q1 2020 | $440,000 | -35.6% | 32,634 | +1.1% | 0.01% | -15.4% |
| Q4 2019 | $683,000 | +69.5% | 32,276 | +6.1% | 0.01% | +62.5% |
| Q3 2019 | $403,000 | -5.6% | 30,424 | -1.3% | 0.01% | -20.0% |
| Q2 2019 | $427,000 | +3.4% | 30,816 | +43.2% | 0.01% | 0.0% |
| Q1 2019 | $413,000 | +40.5% | 21,525 | +4.4% | 0.01% | +25.0% |
| Q4 2018 | $294,000 | -37.7% | 20,621 | +3.3% | 0.01% | -33.3% |
| Q2 2018 | $472,000 | +138.4% | 19,954 | +47.4% | 0.01% | +140.0% |
| Q1 2018 | $198,000 | -10.8% | 13,539 | -1.5% | 0.01% | -16.7% |
| Q4 2017 | $222,000 | +24.0% | 13,749 | +7.6% | 0.01% | 0.0% |
| Q3 2017 | $179,000 | +57.0% | 12,781 | -1.0% | 0.01% | +50.0% |
| Q2 2017 | $114,000 | +48.1% | 12,911 | +8.1% | 0.00% | 0.0% |
| Q1 2017 | $77,000 | +75.0% | 11,945 | -0.2% | 0.00% | +100.0% |
| Q4 2016 | $44,000 | +69.2% | 11,969 | +17.0% | 0.00% | -33.3% |
| Q1 2016 | $26,000 | +52.9% | 10,228 | +0.8% | 0.00% | +50.0% |
| Q3 2015 | $17,000 | – | 10,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|